Patent Assignment
Reel/Frame 030670/0412
Assignment of Assignor's Interest
Recorded: 2013-06-24
Pages: 37
Assignor
NEREUS PHARMACEUTICALS, INC.
Executed: 2012-10-23
Assignee
TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
101 COLLEGE STREET, SUITE 340, TORONTO, M5G 1L7, CANADA
Covered Property
(1)
Compositions and Methods for Treating Neoplastic Diseases
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0850 →
Assignment of Assignor's Interest
Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0860 →
Assignment of Assignor's Interest
Oct 10, 2013
From: ANDERSON, KENNETH C.; CHAUHAN, DHARMINDER
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 031384/0805 →
Assignment of Assignor's Interest
Feb 13, 2017
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 041698/0404 →
Assignment of Assignor's Interest
Jun 11, 2018
From: 1096271 B.C. UNLIMITED LIABILITY COMPANY
To: CELGENE TRI A HOLDINGS LTD.
Reel/Frame 046047/0177 →
Assignment of Assignor's Interest
Jun 11, 2018
From: CELGENE RESEARCH AND DEVELOPMENT I ULC, FORMERLY KNOWN AS TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
To: 1096271 B.C. UNLIMITED LIABILITY COMPANY
Reel/Frame 046047/0201 →
Assignment of Assignor's Interest
Feb 6, 2020
From: CELGENE TRI A HOLDINGS LTD.
To: CELGENE INTERNATIONAL II SARL
Reel/Frame 051741/0848 →